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Background:  Variants in the 4q25 chromosomal region (rs2220425, rs1033464) are associated with atrial fibrillation (AF) in Caucasians. Our aim 
was to determine whether single nucleotide polymorphisms (SNPs) in 4q25 region are associated with postoperative AF, postoperative strokes, long 
term development of AF, long term stroke incidence, and long term survival after coronary artery bypass grafting (CABG).
Methods:  We performed genotyping for rs2200733 and rs10033464 in TexGen cohort. In Caucasian participants (n =1,166), we ascertained the 
development of postoperative AF (PoAF) after CABG or postoperative stroke. Long term AF development, long term stroke development, and long term 
survival were also ascertained.
Results:  Logistic regression analyses showed that rs2200733 and rs1033464 were significantly associated with PoAF (OR1.41. 95% CI 1.04-1.91 
and OR1.47, 95% CI 1.05-2.06, respectively) in the fully adjusted model. The use of beta blockers (BB) appeared to increase the risk of PoAF in the 
carriers of the minor alleles for these SNPs (for rs2200733: OR 1.47, 95% CI 1.004-2.16 for those receiving pre-operative BB and OR 1.13 95% 
CI 0.73-1.73 for those not receiving BB; for rs10033464: OR 1.89, 95% CI 1.22-2.93 for those receiving pre-operative BB and OR 1.04, 95% CI 
0.65-1.65 for those not receiving BB). Cox regression analyses revealed that rs2200733 and rs1033464 were also associated with an increased 
risk of long term AF development (HR 1.32, 95% CI 1.05-1.67, and HR1.28, 95% CI 1.00-1.66, respectively). At a median follow-up of 1,142 days, 
rs2200733 was associated with an increase in long term mortality (HR 1.57, 95% CI 1.10-2.24), whereas no such association was seen with 
rs10033464 (HR 1.04, 95% CI 0.68-1.60). Neither rs2200733 nor rs1033464 were associated with postoperative stroke or long term development 
of stroke.
Conclusions:  Variants in chromosome 4q25 are associated with the development of PoAF, long term AF development, and possibly long term 
mortality in Caucasians undergoing CABG. These variants could stratify postoperative, long term AF risk in these patients, and potentially affect the 
choice of preoperative therapy used to decrease the risk of PoAF.
